Medipost obtains Australian patent for stem cell culturing method

SEARCH
MOBILE

Market Now

Medipost obtains Australian patent for stem cell culturing method

PUBLISHED :June 14, 2017 - 17:38
UPDATED :June 14, 2017 - 17:43

[DISCLOSURE] Medipost (078160) announced on June 14 that it has earned a patent related to a method for culturing mesenchymal stem cells according to cell sizes in Australia.

By Hwang You-mee (theinvestor@heraldcorp.com)

BACK TO LIST TOP

April 26, 2024

Market Now

Medipost obtains Australian patent for stem cell culturing method

EDITOR'S PICKS